Neuroprotective potential of group I metabotropic glutamate receptor antagonists in two ischemic models

Neurochemistry International

Volumn 48, Issue 6-7, 2006, Pages 485-490

  Makarewicz, Dorota ^a   Duszczyk, Małgorzata ^a   Gadamski, Roman ^a   Danysz, Wojciech ^b   Łazarewicz, Jerzy W ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

Brain ischemia; Brain temperature; Group I mGluRs antagonists; Immature rats; Mongolian gerbils; Neuroprotection

Indexed keywords

[(2 METHYL 1,3 THIAZOL 4 YL)ETHYNYL]PYRIDINE; JNJ 16567083; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; NITROGEN; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN SIZE; BRAIN TEMPERATURE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; EVALUATION; FOREBRAIN; GERBIL; HYPERTHERMIA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECTUM TEMPERATURE; TEMPERATURE MEASUREMENT; THERMOREGULATION; WEIGHT REDUCTION;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; BODY TEMPERATURE; BRAIN; BRAIN ISCHEMIA; CAROTID STENOSIS; GERBILLINAE; HIPPOCAMPUS; HYPOXIA-ISCHEMIA, BRAIN; MALE; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE;

ANIMALIA; GERBILLINAE; MERIONES UNGUICULATUS;

EID: 33645846952     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.12.022     Document Type: Article

References (35)

1. Bao W.L., Williams A.J., Faden A.I., and Tortella F.C. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res. 922 (2001) 173-179
2. Bona E., Hagberg H., Loberg E.M., Bagenholm R., and Thoresen M. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr. Res. 43 (1998) 738-745
3. Brodkin J., Bradbury M., Busse C., Warren N., Bristow L.J., and Varney M.A. Reduced stress-induced hyperthermia in mGluR5 knockout mice. Eur. J. Neurosci. 16 (2002) 2241-2244
4. Bruno V., Battaglia G., Kingstone A.E., O'Neill M.J., Catania M.V., Di Grezla R., and Nicoletti F. Neuroprotective activity of the potent and selective mGlu1a metabotropic receptor antagonist (+)-2-methyl-4-carboxylphenyglycine (LY 367385): comparison with LY 357336 a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology 38 (1999) 199-207
5. Bruno V., Battaglia G., Copani A., D'Onofrio M., Di Iorio P., De Blasi A., Melchiorri D., Flor P.J., and Nicoletti F. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J. Cereb. Blood Flow Metab. 21 (2001) 1013-1033
6. Buchan A.M., and Pulsinelli W.A. Hypothermia, but not the N-methyl-d-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischaemia. J. Neurosci. 10 (1990) 311-316
7. Busse C.S., Brodkin J., Tattersall D., Anderson J.J., Warren N., Tehrani L., Bristow L.J., Varney M.A., and Cosford N.D. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 29 (2004) 1971-1979
8. Busto R., Dietrich W.D., Globus M.Y., Valdes I., Scheinberg P., and Ginsberg M.D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7 (1987) 729-738
9. Cambonie G., Kamenka J.M., and Barbanel G. Glutamate inhibition of NMDA-induced hydroxyl radical release: an ontogenic study in rat. Neuroreport 12 (2001) 2035-2039
10. Cambonie G., Laplanche L., Kamenka J.M., and Barbanel G. N-Methyl-d-aspartate but not glutamate induces the release of hydroxyl radicals in the neonatal rat: modulation by group I metabotropic glutamate receptors. J. Neurosci. 62 (2000) 84-90
11. Casabona G., Knopfel T., Kuhn R., Gasparini F., Baumann P., Sortino M.A., Copani A., and Nicoletti F. Expression and coupling to polyphosphoinositide hydrolysis of group I metabotropic glutamate receptors in early postnatal and adult rat brain. Eur. J. Neurosci. 9 (1997) 12-17
12. Corbett D., Nurse S., and Colbourne F. Hypothermic neuroprotection. A global ischemia study using 18- to 20-month-old gerbils. Stroke 28 (1997) 2238-2243
13. Dietrich W.D., Lin B., Globus M., Green E.J., Ginsberg M.D., and Busto R. Efect of delayed MK-801 (Dizocilipine) treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 15 (1995) 960-968
14. Duszczyk M., Gadamski R., Ziembowicz A., Danysz W., and Lazarewicz J.W. NMDA receptor antagonism does not inhibit induction of ischemic tolerance in gerbil brain in vivo. Neurotoxicol. Res. 7 (2005) 283-292
15. Duszczyk M., Gadamski R., Ziembowicz A., and Lazarewicz J.W. Antagonists of group I metabotropic glutamate receptors do not inhibit induction of ischemic tolerance in gerbil hippocampus. Neurochem. Int. 48 (2006) 478-484
16. Gilland E., and Hagberg H. Is MK-801 neuroprotection mediated by systemic hypothermia in the immature rat?. Neuroreport 8 (1997) 1603-1605
17. Ikonomidou C., Bittigau P., Koch C., Genz K., Hoerster F., Felderhoff-Mueser U., Tenkova T., Dikranian K., and Olney J.W. Neurotransmitters and apoptosis in the developing brain. Biochem. Pharmacol. 62 (2000) 401-405
18. Kuroiwa T.P., Bonnekoh, and Hossmann K.A. Prevention of postischemic hyperthermia prevents ischemic injury of CA1 neurons in gerbils. J. Cereb. Blood Flow Metab. 10 (1990) 550-556
19. Lesage A.S.J., Bischoff F., Van Beijsterveldt L., Meert T., Steckler T., and Ashton D. Novel, centrally active mGluR1 antagonists: in vitro and in vivo pharmacology. Neuropharmacology 43 (2002) 295
20. Lopez-Bendito G., Shigemoto R., Fairen A., and Lujan R. Differential distribution of group I metabotropic glutamate receptors during rat cortical development. Cereb. Cortex. 12 (2002) 625-638
21. Makarewicz D., Gadamski R., Ziembowicz A., Kozikowski A.P., Wroblewski J.T., and Lazarewicz J.W. Neuroprotective effects of the agonist of metabotropic glutamate receptors ABHxD-I in two animal models of cerebral ischaemia. Resuscitation 68 (2006) 119-126
22. Meli E., Picca R., Scheideler M.A., Pellicciari R., Noe C., Sarichelou I., and Pellegrini-Giampietro D.E. The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology 42 (2002) 741-751
23. Moroni F., Attucci S., Cozzi A., Meli E., Picca R., Scheideler M.A., Pellicciari R., Noe C., Sarichelou I., and Pellegrini-Giampietro D.E. The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology 42 (2002) 741-751
24. Nicoletti F., Bruno V., Catania M.V., Battaglia G., Copani A., Barbagallo G., Cena V., Sanchezprieto J., Spano P.F., and Pizzi M. Group I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology 38 (1999) 1477-1484
25. Nurse S., and Corbett D. Neuroprotection after several days of mild, drug induced hypothermia. J. Cereb. Blood Flow Metab. 16 (1996) 474-480
26. Pellegrini-Giampietro D.E., Peruginelli F., Meli E., Cozzi A., Albani-Torregrossa S., Pellicciari R., and Moroni F. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms. Neuropharmacology 38 (1999) 1607-1619
27. Pietraszek M., Graviusm A., Schaferm D., Weil T., Trifanova D., and Danysz W. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition. Neuropharmacology 49 (2005) 73-85
28. Pietraszek M., Sukhanov I., Maciejak P., Szyndler J., Gravius A., Wislowska A., Planik A., Bespalov A.Y., and Danysz W. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur. J. Pharmacol. 514 (2005) 25-34
29. Pohl D., Bittigau P., Ishimaru M.J., Stadthaus D., Hubner C., Olney J.W., Turski L., and Ikonomidou C. N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2508-2513
30. Rao A.M., Hatcher J.F., and Dempsey R.J. Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil. Neurosci. Lett. 293 (2000) 1-4
31. Rice J.E., Vannucci R.C., and Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9 (1981) 131-141
32. Roohey T., Raju T.N., and Moustogiannis A.N. Animal models for the study of perinatal hypoxic-ischemic encephalopathy: a critical analysis. Early Hum. Dev. 47 (1997) 115-146
33. van den Pol A.N., Kogelman L., Ghosh P., Liljelund P., and Blackstone C. Developmental regulation of the hypothalamic metabotropic glutamate receptor mGluR1. J. Neurosci. 14 (1994) 3816-3834
34. Vannucci S.J., and Hagberg H. Hypoxia-ischemia in the immature brain. J. Exp. Biol. 207 (2004) 3149-3154
35. Volpe J.J. Perinatal brain injury: from pathogenesis to neuroprotection. Ment. Retard. Dev. Disabil. Res. Rev. 7 (2001) 56-64